Whole blood transfusions are declining—replaced by targeted component therapy. Platelets for bleeding, red cells for anemia, plasma for clotting—component therapy improves outcomes. This shift is shaping the blood preparation market.
Within the Blood Preparation Market, component therapy is growing. Components are prepared for specific needs.
Geographically, adoption is strongest...
